Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-360906
Filing Date
2021-12-17
Accepted
2021-12-17 14:36:02
Documents
2
Group Members
ALBERT CHAFHMLS X, L.L.C.FHMLS X, L.P.FHMLSP, L.L.C.FHMLSP, L.P.FRAZIER LIFE SCIENCES X, L.P.JAMES BRUSHJAMES N. TOPPERPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SC 13G d273935dsc13g.htm SC 13G 178985
2 EX-99.A d273935dex99a.htm EX-99.A 16948
  Complete submission text file 0001193125-21-360906.txt   197790
Mailing Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111 415 877 4887
FS Development Corp. II (Subject) CIK: 0001822711 (see all company filings)

EIN.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93142 | Film No.: 211501015
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO UNION SQUARE, 601 UNION ST. SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION ST. SUITE 3200 SEATTLE WA 98101 650-325-5156
Frazier Life Sciences Public Fund, L.P. (Filed by) CIK: 0001863769 (see all company filings)

EIN.: 862999645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G